0001567619-21-006209.txt : 20210312
0001567619-21-006209.hdr.sgml : 20210312
20210312160639
ACCESSION NUMBER: 0001567619-21-006209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210310
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalra Balkrishan
CENTRAL INDEX KEY: 0001768217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33626
FILM NUMBER: 21737443
MAIL ADDRESS:
STREET 1: 5 MARION AVENUE
CITY: SHORT HILLS
STATE: NJ
ZIP: 07078
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genpact LTD
CENTRAL INDEX KEY: 0001398659
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 980533350
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
BUSINESS PHONE: 4412952244
MAIL ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
4
1
doc1.xml
FORM 4
X0306
4
2021-03-10
0
0001398659
Genpact LTD
G
0001768217
Kalra Balkrishan
C/O GENPACT LLC
1155 AVENUE OF THE AMERICAS, 4TH FLOOR
NEW YORK
NY
10036
0
1
0
0
Senior Vice President
Common Shares
2021-03-10
4
S
0
2147
42.3571
D
164823
D
Common Shares
2021-03-11
4
S
0
1000
42.718
D
163823
D
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.350 to $42.375. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Includes 615 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 13, 2021. The reporting person currently holds a total of 6,074 shares under the ESPP.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.70 to $42.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ Thomas D. Scholtes as Attorney-in-fact for Balkrishan Kalra
2021-03-12